Antibody Drug Conjugate Adc Patentability Cases

Explore 1 court opinions on Antibody Drug Conjugate Adc Patentability. AI-powered plain English summaries, key holdings, and legal analysis.

1 recent cases analyzed in this topic area.

Courts Deciding Antibody Drug Conjugate Adc Patentability Cases

cafc (1)

Recent Antibody Drug Conjugate Adc Patentability Opinions (1)

Seagen Inc. v. Daiichi Sankyo Company, Ltd.

CAFC Affirms PTAB Decision, Upholding Seagen's Cancer Drug Patent

cafc · 2025-12-02 · Defendant Win · Impact: 30/100

Seagen Inc. v. Daiichi Sankyo Company, Ltd., decided by Federal Circuit on December 2, 2025, resulted in a defendant win outcome. The core dispute centered on whether Daiichi Sankyo's patent for a can...

Antibody Drug Conjugate Adc Patentability by Court

Supreme Court First Circuit Second Circuit Third Circuit Fourth Circuit Fifth Circuit Sixth Circuit Seventh Circuit Eighth Circuit Ninth Circuit Tenth Circuit Eleventh Circuit D.C. Circuit Federal Circuit

Antibody Drug Conjugate Adc Patentability by State

California Texas New York Florida Illinois Pennsylvania Ohio Georgia Michigan New Jersey Virginia Washington Massachusetts North Carolina

Related Resources

antibody-drug-conjugate-adc-patentability Legal Definition antibody-drug-conjugate-adc-patentability Practice Area Guide antibody-drug-conjugate-adc-patentability Landmarks Home Search Cases States Courts Topic Rankings